BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31263571)

  • 1. High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer.
    Bertelsen B; Tuxen IV; Yde CW; Gabrielaite M; Torp MH; Kinalis S; Oestrup O; Rohrberg K; Spangaard I; Santoni-Rugiu E; Wadt K; Mau-Sorensen M; Lassen U; Nielsen FC
    NPJ Genom Med; 2019; 4():13. PubMed ID: 31263571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer.
    Okawa Y; Iwasaki Y; Johnson TA; Ebata N; Inai C; Endo M; Maejima K; Sasagawa S; Fujita M; Matsuda K; Murakami Y; Nakamura T; Hirano S; Momozawa Y; Nakagawa H
    J Hepatol; 2023 Feb; 78(2):333-342. PubMed ID: 36243179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pathogenic germline variants identified in mesothelioma.
    Belcaid L; Bertelsen B; Wadt K; Tuxen I; Spanggaard I; Højgaard M; Benn Sørensen J; Ravn J; Lassen U; Cilius Nielsen F; Rohrberg K; Westmose Yde C
    Lung Cancer; 2023 May; 179():107172. PubMed ID: 36944283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Testing for Somatic and Germline
    Peixoto A; Pinto P; Guerra J; Pinheiro M; Santos C; Pinto C; Santos R; Escudeiro C; Bartosch C; Canário R; Barbosa A; Gouveia A; Petiz A; Abreu MH; Sousa S; Pereira D; Silva J; Teixeira MR
    Front Oncol; 2020; 10():1318. PubMed ID: 32850417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patients.
    Yoon JY; Roth JJ; Rushton CA; Morrissette JJD; Nathanson KL; Cohen RB; Rosenbaum JN
    Transl Lung Cancer Res; 2023 Jun; 12(6):1236-1244. PubMed ID: 37425424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline testing for homologous recombination repair genes-opportunities and challenges.
    Hirsch S; Gieldon L; Sutter C; Dikow N; Schaaf CP
    Genes Chromosomes Cancer; 2021 May; 60(5):332-343. PubMed ID: 33078493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer.
    Adamson AW; Ding YC; Steele L; Leong LA; Morgan R; Wakabayashi MT; Han ES; Dellinger TH; Lin PS; Hakim AA; Wilczynski S; Warden CD; Tao S; Bedell V; Cristea MC; Neuhausen SL
    Res Sq; 2023 Feb; ():. PubMed ID: 36865331
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.
    Meric-Bernstam F; Brusco L; Daniels M; Wathoo C; Bailey AM; Strong L; Shaw K; Lu K; Qi Y; Zhao H; Lara-Guerra H; Litton J; Arun B; Eterovic AK; Aytac U; Routbort M; Subbiah V; Janku F; Davies MA; Kopetz S; Mendelsohn J; Mills GB; Chen K
    Ann Oncol; 2016 May; 27(5):795-800. PubMed ID: 26787237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management.
    McGee RB; Oak N; Harrison L; Xu K; Nuccio R; Blake AK; Mostafavi R; Lewis S; Taylor LM; Kubal M; Ouma A; Hines-Dowell SJ; Cheng C; Furtado LV; Nichols KE
    Clin Cancer Res; 2023 Apr; 29(7):1243-1251. PubMed ID: 36693186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline Pathogenic Variants in Homologous Recombination and DNA Repair Genes in an Asian Cohort of Young-Onset Colorectal Cancer.
    Toh MR; Chiang JB; Chong ST; Chan SH; Ishak NDB; Courtney E; Lee WH; Syed Abdillah Al SMFB; Carson Allen J; Lim KH; Davila S; Tan P; Lim WK; Tan IBH; Ngeow J
    JNCI Cancer Spectr; 2018 Oct; 2(4):pky054. PubMed ID: 31360874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted sequencing to discover germline variants in the BRCA1 and BRCA2 genes in a Russian population and their association with breast cancer risk.
    Solodskikh SA; Panevina AV; Gryaznova MV; Gureev AP; Serzhantova OV; Mikhailov AA; Maslov AY; Popov VN
    Mutat Res; 2019 Jan; 813():51-57. PubMed ID: 30611917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients.
    Rodríguez-Balada M; Roig B; Melé M; Albacar C; Serrano S; Salvat M; Querol M; Borràs J; Martorell L; Gumà J
    Clin Biochem; 2020 Feb; 76():17-23. PubMed ID: 31786208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants.
    Schubert S; van Luttikhuizen JL; Auber B; Schmidt G; Hofmann W; Penkert J; Davenport CF; Hille-Betz U; Wendeburg L; Bublitz J; Tauscher M; Hackmann K; Schröck E; Scholz C; Wallaschek H; Schlegelberger B; Illig T; Steinemann D
    Int J Cancer; 2019 Jun; 144(11):2683-2694. PubMed ID: 30426508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines.
    Yap TA; Ashok A; Stoll J; Mauer E; Nepomuceno VM; Blackwell KL; Garber JE; Meric-Bernstam F
    JAMA Netw Open; 2022 May; 5(5):e2213070. PubMed ID: 35594047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer.
    Hirasawa A; Imoto I; Naruto T; Akahane T; Yamagami W; Nomura H; Masuda K; Susumu N; Tsuda H; Aoki D
    Oncotarget; 2017 Dec; 8(68):112258-112267. PubMed ID: 29348823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers.
    Domagala P; Jakubowska A; Jaworska-Bieniek K; Kaczmarek K; Durda K; Kurlapska A; Cybulski C; Lubinski J
    PLoS One; 2015; 10(6):e0130393. PubMed ID: 26083025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
    Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
    BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
    Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
    Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.